{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:21:16Z","timestamp":1787682076431,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84479-w","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:06:06Z","timestamp":1736744766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases"],"prefix":"10.1038","volume":"15","author":[{"given":"Fikret","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslihan","family":"Gunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buse Turegun","family":"Atasoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulku","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isinsu","family":"Kuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Taspinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda","family":"Kahveci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"84479_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24152841","volume":"24","author":"CL Jones","year":"2019","unstructured":"Jones, C. L. & Tepe, J. J. Proteasome Activation to Combat Proteotoxicity. Molecules 24, 1\u201328 (2019).","journal-title":"Molecules"},{"key":"84479_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mam.2016.05.001","volume":"50","author":"R Raynes","year":"2016","unstructured":"Raynes, R., Pomatto, L. C. D. & Davies, K. J. A. Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways. Mol. Aspects Med. 50, 41\u201355 (2016).","journal-title":"Mol. Aspects Med."},{"key":"84479_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/iub.114","volume":"60","author":"T Jung","year":"2008","unstructured":"Jung, T. & Grune, T. The Proteasome and Its Role in the Degradation of Oxidized Proteins. IUBMB Life 60, 743\u2013752 (2008).","journal-title":"IUBMB Life"},{"key":"84479_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","volume":"24","author":"MS Hipp","year":"2014","unstructured":"Hipp, M. S., Park, S. H. & Hartl, F. U. Proteostasis impairment in protein misfolding and -aggregation diseases. Trends Cell Biol. 24, 506\u2013514 (2014).","journal-title":"Trends Cell Biol."},{"key":"84479_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","volume":"169","author":"GA Collins","year":"2017","unstructured":"Collins, G. A. & Goldberg, A. L. The Logic of the 26S Proteasome. Cell 169, 792\u2013806 (2017).","journal-title":"Cell"},{"key":"84479_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-397863-9.00006-7","volume":"109","author":"AM Pickering","year":"2012","unstructured":"Pickering, A. M. & Davies, K. J. Degradation of damaged proteins: the main function of the 20S proteasome. Prog. Mol. Biol. Transl. Sci. 109, 227\u2013248 (2012).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"84479_CR7","first-page":"1","volume":"9","author":"FK Deshmukh","year":"2019","unstructured":"Deshmukh, F. K. et al. The Contribution of the 20S Proteasome to Proteostasis. Biomolecules 9, 1\u201316 (2019).","journal-title":"Biomolecules"},{"key":"84479_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/bs.ircmb.2016.08.011","volume":"329","author":"L Breydo","year":"2017","unstructured":"Breydo, L., Redington, J. M. & Uversky, V. N. Effects of Intrinsic and Extrinsic Factors on Aggregation of Physiologically Important Intrinsically Disordered Proteins. Int. Rev. Cell Mol. Biol. 329, 145\u2013185 (2017).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"84479_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11121789","volume":"11","author":"DE George","year":"2021","unstructured":"George, D. E. & Tepe, J. J. Advances in Proteasome Enhancement by Small Molecules. Biomolecules 11, 1\u201327 (2021).","journal-title":"Biomolecules"},{"key":"84479_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","volume":"49","author":"H Krystal","year":"2023","unstructured":"Krystal, H., Kavalali, E. T. & Monteggia, L. M. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Neuropsychopharmacology 49, 41\u201350 (2023).","journal-title":"Neuropsychopharmacology"},{"key":"84479_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells12182318","volume":"12","author":"N Sanghai","year":"2023","unstructured":"Sanghai, N. & Tranmer, G. K. Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View. Cells 12, 1\u201320 (2023).","journal-title":"Cells"},{"key":"84479_CR12","first-page":"1","volume":"28","author":"AV Ciurea","year":"2023","unstructured":"Ciurea, A. V. et al. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s Diseases and Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 28, 1\u201324 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"84479_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuroscience.2019.12.002","volume":"454","author":"BJ Moraes","year":"2021","unstructured":"Moraes, B. J. et al. Modified Glutamatergic Postsynapse in Neurodegenerative Disorders. Neuroscience 454, 116\u2013139 (2021).","journal-title":"Neuroscience"},{"key":"84479_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn2717","volume":"10","author":"TJ Ryan","year":"2009","unstructured":"Ryan, T. J. & Grant, S. G. The origin and evolution of synapses. Nat. Rev. Neurosci. 10, 701\u2013712 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"84479_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-neuro-062111-150442","volume":"35","author":"JT Ting","year":"2012","unstructured":"Ting, J. T., Pe\u00e7a, J. & Feng, G. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu. Rev. Neurosci. 35, 49\u201371 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"84479_CR16","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s11011-023-01236-0","volume":"38","author":"GH Wu","year":"2023","unstructured":"Wu, G. H. et al. Ketamine exerts dual effects on the apoptosis of primary cultured hippocampal neurons from fetal rats in vitro. Metab. Brain Dis. 38, 2417\u20132426 (2023).","journal-title":"Metab. Brain Dis."},{"key":"84479_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0076-6879(05)98030-0","volume":"398","author":"A Kisselev","year":"2005","unstructured":"Kisselev, A. & Goldberg, A. L. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol. 398, 364\u2013378 (2005).","journal-title":"Methods Enzymol."},{"key":"84479_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2019.00014","volume":"6","author":"J Gan","year":"2019","unstructured":"Gan, J. et al. Highlighting the Proteasome: Using Fluorescence to Visualize Proteasome Activity and Distribution. Front. Mol. Biosci. 6, 1\u20138 (2019).","journal-title":"Front. Mol. Biosci."},{"key":"84479_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature09299","volume":"467","author":"KS McNaught","year":"2010","unstructured":"McNaught, K. S. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179\u2013184 (2010).","journal-title":"Nature"},{"key":"84479_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neuron.2019.05.002","volume":"103","author":"F Koopmans","year":"2019","unstructured":"Koopmans, F. et al. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse. Neuron 103, 217\u2013234 (2019).","journal-title":"Neuron"},{"key":"84479_CR21","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1016\/j.cell.2023.09.028","volume":"186","author":"M van Oostrum","year":"2023","unstructured":"van Oostrum, M. et al. The proteomic landscape of synaptic diversity across brain regions and cell types. Cell 186, 5411\u20135427 (2023).","journal-title":"Cell"},{"key":"84479_CR22","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protocol. 1, e90 (2021).","journal-title":"Curr. Protocol."},{"issue":"W1","key":"84479_CR23","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucl. Acids Res. 50(W1), W216\u2013W221 (2022).","journal-title":"Nucl. Acids Res."},{"key":"84479_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-physiol-030212-183711","volume":"75","author":"J Kumar","year":"2013","unstructured":"Kumar, J. & Mayer, M. L. Functional insights from glutamate receptor ion channel structures. Annu. Rev. Physiol. 75, 313\u2013337 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"84479_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbrc.2019.08.025","volume":"518","author":"K Hirano","year":"2019","unstructured":"Hirano, K. et al. Neuroprotective effects of memantine via enhancement of autophagy. Biochem. Biophys. Res. Commun. 518, 161\u2013170 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"84479_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cptx.11","volume":"69","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. Methods for the Detection of Autophagy in Mammalian Cells. Curr. Protoc. Toxicol. 69, 1\u201320 (2016).","journal-title":"Curr. Protoc. Toxicol."},{"key":"84479_CR27","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/hmg\/ddi312","volume":"14","author":"V Menendez-Benito","year":"2005","unstructured":"Menendez-Benito, V. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. Hum. Mol. Genet. 14, 2787\u20132789 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"84479_CR28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2007.05.028","volume":"26","author":"X Li","year":"2007","unstructured":"Li, X. et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol. Cell. 26, 831\u2013842 (2007).","journal-title":"Mol. Cell."},{"key":"84479_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrc1881","volume":"6","author":"KI Nakayama","year":"2006","unstructured":"Nakayama, K. I. & Nakayama, K. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369\u2013381 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"84479_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.1160462","volume":"322","author":"HS Yen","year":"2008","unstructured":"Yen, H. S. & Elledg, S. J. Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 322, 923\u2013929 (2008).","journal-title":"Science"},{"key":"84479_CR31","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.chembiol.2018.07.012","volume":"25","author":"J Li","year":"2018","unstructured":"Li, J. et al. Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11. Cell Chem. Biol. 25, 1350\u20131358 (2018).","journal-title":"Cell Chem. Biol."},{"key":"84479_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1074-5521(00)80016-2","volume":"6","author":"M Kroll","year":"1999","unstructured":"Kroll, M. et al. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem. Biol. 6, 689\u2013698 (1999).","journal-title":"Chem. Biol."},{"key":"84479_CR33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.freeradbiomed.2011.06.015","volume":"51","author":"T Grune","year":"2011","unstructured":"Grune, T. et al. HSP70 Mediates Dissociation and Reassociation of the 26S Proteasome During Adaptation to Oxidative Stress. Free Radic Biol. Med. 51, 1355\u20131364 (2011).","journal-title":"Free Radic Biol. Med."},{"key":"84479_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.freeradbiomed.2011.03.031","volume":"51","author":"F Shang","year":"2011","unstructured":"Shang, F. & Taylor, A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic. Biol. Med. 51, 5\u201316 (2011).","journal-title":"Free Radic. Biol. Med."},{"key":"84479_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.abb.2012.04.018","volume":"523","author":"AM Pickering","year":"2012","unstructured":"Pickering, A. M. & Davies, K. J. A. Differential Roles of Proteasome and Immunoproteasome Regulators Pa28\u03b1\u03b2, Pa28\u03b3 and Pa200 in the Degradation of Oxidized Proteins. Arch. Biochem. Biophys. 523, 181\u2013190 (2012).","journal-title":"Arch. Biochem. Biophys."},{"key":"84479_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nmeth.4083","volume":"14","author":"T Li","year":"2017","unstructured":"Li, T. et al. A scored human protein-protein interaction network to catalyze genomic interpretation. Nat. Methods 14, 61\u201364 (2017).","journal-title":"Nat. Methods"},{"key":"84479_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/9296092","volume":"9296092","author":"AA Anand","year":"2023","unstructured":"Anand, A. A., Khan, M. & Kar, M. V. D. The Molecular Basis of Wnt\/\u03b2-Catenin Signaling Pathways in Neurodegenerative Diseases. Int. J. Cell Biol. 9296092, 1\u201313 (2023).","journal-title":"Int. J. Cell Biol."},{"key":"84479_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom13091388","volume":"13","author":"V Voicu","year":"2023","unstructured":"Voicu, V. et al. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules 13, 1\u201345 (2023).","journal-title":"Biomolecules"},{"key":"84479_CR39","first-page":"1","volume":"4","author":"J Chakraborty","year":"2023","unstructured":"Chakraborty, J. et al. Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders. Biochim. Biophys. Acta Gene Regul. Mech. 4, 1\u201314 (2023).","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"84479_CR40","doi-asserted-by":"crossref","unstructured":"Zadka, \u0141., et al., Endocytosis and Alzheimer\u2019s disease. Geroscience 46, 71-85 (2023).","DOI":"10.1007\/s11357-023-00923-1"},{"key":"84479_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/alz.12653","volume":"2","author":"G Zuniga","year":"2023","unstructured":"Zuniga, G. et al. Tau-induced deficits in nonsense-mediated mRNA decay contribute to neurodegeneration. Alzheimers Dement. 2, 405\u2013420 (2023).","journal-title":"Alzheimers Dement."},{"key":"84479_CR42","first-page":"1","volume":"1","author":"S Rimal","year":"2021","unstructured":"Rimal, S. et al. Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 1, 1\u201324 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"84479_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/112_2022_72","volume":"186","author":"AA Ghazy","year":"2023","unstructured":"Ghazy, A. A. et al. Role of Oxytocin in Different Neuropsychiatric, Neurodegenerative, and Neurodevelopmental Disorders. Rev. Physiol. Biochem. Pharmacol. 186, 95\u2013134 (2023).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"84479_CR44","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/pmic.201400515","volume":"15","author":"M Pat","year":"2015","unstructured":"Pat, M. et al. FunRich: An open access standalone functional enrichment and interaction network analysis tool. Proteomics 15, 2597\u20132601 (2015).","journal-title":"Proteomics"},{"key":"84479_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucl. Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucl. Acids Res."},{"key":"84479_CR46","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucl. Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucl. Acids Res."},{"key":"84479_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-neuro-080317-062155","volume":"41","author":"HR Monday","year":"2018","unstructured":"Monday, H. R., Younts, T. J. & Castillo, P. E. Long-Term Plasticity of Neurotransmitter Release: Emerging Mechanisms and Contributions to Brain Function and Disease. Annu. Rev. Neurosci. 41, 299\u2013322 (2018).","journal-title":"Annu. Rev. Neurosci."},{"key":"84479_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nlm.2016.09.003","volume":"138","author":"AN Hegde","year":"2017","unstructured":"Hegde, A. N. Proteolysis, synaptic plasticity and memory. Neurobiol. Learn Mem. 138, 98\u2013110 (2017).","journal-title":"Neurobiol. Learn Mem."},{"key":"84479_CR49","first-page":"1","volume":"10","author":"CH Tu","year":"2019","unstructured":"Tu, C. H., MacDonald, I. & Chen, Y. H. The Effects of Acupuncture on Glutamatergic Neurotransmission in Depression, Anxiety, Schizophrenia, and Alzheimer\u2019s Disease: A Review of the Literature. Front Psych. 10, 1\u201312 (2019).","journal-title":"Front Psych."},{"key":"84479_CR50","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","volume":"98","author":"A Reiner","year":"2018","unstructured":"Reiner, A. & Levitz, J. Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert. Neuron 98, 1080\u20131098 (2018).","journal-title":"Neuron"},{"key":"84479_CR51","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1111\/j.1460-9568.2012.08165.x","volume":"35","author":"PK Chang","year":"2012","unstructured":"Chang, P. K., Verbich, D. & McKinney, R. A. AMPA receptors as drug targets in neurological disease\u2013advantages, caveats, and future outlook. Eur. J. Neurosci. 35, 1908\u20131916 (2012).","journal-title":"Eur. J. Neurosci."},{"key":"84479_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph16050742","volume":"16","author":"P Borsellino","year":"2023","unstructured":"Borsellino, P. et al. Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression. Pharmaceuticals (Basel) 16, 1\u201319 (2023).","journal-title":"Pharmaceuticals (Basel)"},{"key":"84479_CR53","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nn1381","volume":"8","author":"Y Ji","year":"2005","unstructured":"Ji, Y. et al. Cyclic AMP Controls BDNF-Induced TrkB Phosphorylation and Dendritic Spine Formation in Mature Hippocampal Neurons. Nat. Neurosci. 8, 164\u2013172 (2005).","journal-title":"Nat. Neurosci."},{"key":"84479_CR54","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrn2738","volume":"10","author":"L Minichiello","year":"2009","unstructured":"Minichiello, L. TrkB Signalling Pathways in LTP and Learning. Nat. Rev. Neurosci. 10, 850\u2013860 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"84479_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/bcpt.13598","volume":"129","author":"S Kohtala","year":"2021","unstructured":"Kohtala, S. & Rantam\u00e4ki, T. Rapid-acting antidepressants and the regulation of TrkB neurotrophic signalling-Insights from ketamine, nitrous oxide, seizures and anaesthesia. Basic Clin. Pharmacol. Toxicol. 129, 95\u2013103 (2021).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"84479_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","volume":"112","author":"MF Egan","year":"2003","unstructured":"Egan, M. F. et al. The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function. Cell 112, 257\u2013269 (2003).","journal-title":"Cell"},{"key":"84479_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuron.2020.05.015","volume":"106","author":"ET Kavalali","year":"2020","unstructured":"Kavalali, E. T. & Monteggia, L. M. Targeting homeostatic synaptic plasticity for treatment of mood disorders. Neuron 106, 715\u2013726 (2020).","journal-title":"Neuron"},{"key":"84479_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41386-022-01411-4","volume":"48","author":"ET Kavalali","year":"2023","unstructured":"Kavalali, E. T. & Monteggia, L. M. Rapid homeostatic plasticity and neuropsychiatric therapeutics. Neuropsychopharmacology 48, 54\u201360 (2023).","journal-title":"Neuropsychopharmacology"},{"key":"84479_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2021.108736","volume":"197","author":"BL Winters","year":"2021","unstructured":"Winters, B. L. & Vaughan, C. W. Mechanisms of endocannabinoid control of synaptic plasticity. Neuropharmacology 197, 1\u201323 (2021).","journal-title":"Neuropharmacology"},{"key":"84479_CR60","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41586-023-06624-1","volume":"622","author":"S Ma","year":"2023","unstructured":"Ma, S. et al. Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb. Nature 622, 802\u2013809 (2023).","journal-title":"Nature"},{"key":"84479_CR61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.9758\/cpn.2017.15.3.210","volume":"15","author":"A Singh","year":"2017","unstructured":"Singh, A. & Kar, S. K. How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms. Clin Psychopharmacol. Neurosci. 15, 210\u2013221 (2017).","journal-title":"Clin Psychopharmacol. Neurosci."},{"key":"84479_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2014.10.020","volume":"1593","author":"SM O'Donovan","year":"2014","unstructured":"O\u2019Donovan, S. M. et al. The persisting effects of electroconvulsive stimulation on the hippocampal proteome. Brain Res. 1593, 106\u2013116 (2014).","journal-title":"Brain Res."},{"key":"84479_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2023.109857","volume":"752","author":"B Saikia","year":"2024","unstructured":"Saikia, B. & Baruah, A. Recent advances in de novo computational design and redesign of intrinsically disordered proteins and intrinsically disordered protein regions. Arch. Biochem. Biophys. 752, 1\u201310 (2024).","journal-title":"Arch. Biochem. Biophys."},{"key":"84479_CR64","doi-asserted-by":"publisher","first-page":"22362","DOI":"10.1016\/S0021-9258(18)41680-8","volume":"267","author":"L Hoffman","year":"1992","unstructured":"Hoffman, L. et al. Multiple forms of the 20 S multicatalytic and the 26 S ubiquitin\/ATP-dependent proteases from rabbit reticulocyte lysate. J. Biol. Chem. 267, 22362\u201322368 (1992).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84479-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:06:14Z","timestamp":1736744774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84479-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84479"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84479-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4973153\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FS is the inventor of the \u201cEnhancing Proteasome Activity by NMDAR Antagonists Explains Their Therapeutic Effect in Neurodegenerative and Mental Diseases\u201d mentioned in this publication. The patent application was filed by FS. The other authors do not have any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1165"}}